Blood holds clues to liver cancer treatment response
NCT ID NCT07378709
Summary
This study aims to learn if simple blood tests can predict or monitor how well a standard liver cancer treatment works. Researchers will observe 15 adult patients with liver cancer who are scheduled to receive a procedure called TACE. They will collect blood samples before and after treatment to see if changes in certain markers match up with how the tumor responds on follow-up scans.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KBC Bežanijska kosa
RECRUITINGBelgrade, Serbia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.